Connect with us

General

Interleukin-6 antagonists improve outcomes in hospitalised COVID-19 patients

Findings from a study published today [6 July] in the Journal of the American Medical Association (JAMA) have prompted new World Health Organization (WHO) recommendations to use interleukin-6 antagonists in patients with severe or critical COVID-19 along with corticosteroids.

Exit mobile version